Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonists.
D000818:Animals; D002064:Buserelin; D003864:Depression, Chemical; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000502:physiology*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D011962:Receptors, FSH; D011974:Receptors, LH; D011981:Receptors, Prolactin; D013737:Testis / Q000187:drug effects* / Q000378:metabolism
D011956:Receptors, Cell Surface; D011962:Receptors, FSH; D011974:Receptors, LH; D011981:Receptors, Prolactin; D007987:Gonadotropin-Releasing Hormone; C010661:surfagon; D002064:Buserelin